These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression levels of the α7 nicotinic acetylcholine receptor in the brains of patients with Alzheimer's disease and their effect on synaptic proteins in SH-SY5Y cells. Ren JM; Zhang SL; Wang XL; Guan ZZ; Qi XL Mol Med Rep; 2020 Sep; 22(3):2063-2075. PubMed ID: 32582986 [TBL] [Abstract][Full Text] [Related]
3. Selective coactivation of α7- and α4β2-nicotinic acetylcholine receptors reverses beta-amyloid-induced synaptic dysfunction. Roberts JP; Stokoe SA; Sathler MF; Nichols RA; Kim S J Biol Chem; 2021; 296():100402. PubMed ID: 33571523 [TBL] [Abstract][Full Text] [Related]
4. Temporal changes of CD68 and α7 nicotinic acetylcholine receptor expression in microglia in Alzheimer's disease-like mouse models. Matsumura A; Suzuki S; Iwahara N; Hisahara S; Kawamata J; Suzuki H; Yamauchi A; Takata K; Kitamura Y; Shimohama S J Alzheimers Dis; 2015; 44(2):409-23. PubMed ID: 25352454 [TBL] [Abstract][Full Text] [Related]
5. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain. Ni R; Marutle A; Nordberg A J Alzheimers Dis; 2013; 33(3):841-51. PubMed ID: 23042213 [TBL] [Abstract][Full Text] [Related]
6. Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease. Hernandez CM; Kayed R; Zheng H; Sweatt JD; Dineley KT J Neurosci; 2010 Feb; 30(7):2442-53. PubMed ID: 20164328 [TBL] [Abstract][Full Text] [Related]
7. The Abeta1-42M35C mutated amyloid peptide Abeta1-42 and the 25-35 fragment fail to mimic the subtype-specificity of actions on recombinant human nicotinic acetylcholine receptors (alpha7, alpha4beta2, alpha3beta4). Pym LJ; Buckingham SD; Tsetlin V; Boyd CA; Sattelle DB Neurosci Lett; 2007 Oct; 427(1):28-33. PubMed ID: 17945421 [TBL] [Abstract][Full Text] [Related]
8. Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease. Counts SE; He B; Che S; Ikonomovic MD; DeKosky ST; Ginsberg SD; Mufson EJ Arch Neurol; 2007 Dec; 64(12):1771-6. PubMed ID: 18071042 [TBL] [Abstract][Full Text] [Related]
10. α7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles. Medeiros R; Castello NA; Cheng D; Kitazawa M; Baglietto-Vargas D; Green KN; Esbenshade TA; Bitner RS; Decker MW; LaFerla FM Am J Pathol; 2014 Feb; 184(2):520-9. PubMed ID: 24269557 [TBL] [Abstract][Full Text] [Related]
11. Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease. Dineley KT; Westerman M; Bui D; Bell K; Ashe KH; Sweatt JD J Neurosci; 2001 Jun; 21(12):4125-33. PubMed ID: 11404397 [TBL] [Abstract][Full Text] [Related]
12. beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. Wang HY; Lee DH; D'Andrea MR; Peterson PA; Shank RP; Reitz AB J Biol Chem; 2000 Feb; 275(8):5626-32. PubMed ID: 10681545 [TBL] [Abstract][Full Text] [Related]
13. On the interaction of β-amyloid peptides and α7-nicotinic acetylcholine receptors in Alzheimer's disease. Oz M; Lorke DE; Yang KH; Petroianu G Curr Alzheimer Res; 2013 Jul; 10(6):618-30. PubMed ID: 23627750 [TBL] [Abstract][Full Text] [Related]
15. Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease. Lilja AM; Porras O; Storelli E; Nordberg A; Marutle A J Alzheimers Dis; 2011; 23(2):335-47. PubMed ID: 21116052 [TBL] [Abstract][Full Text] [Related]
16. Suppressed expression of nicotinic acetylcholine receptors by nanomolar beta-amyloid peptides in PC12 cells. Guan ZZ; Miao H; Tian JY; Unger C; Nordberg A; Zhang X J Neural Transm (Vienna); 2001; 108(12):1417-33. PubMed ID: 11810405 [TBL] [Abstract][Full Text] [Related]
17. A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease. Xia W; Yang T; Shankar G; Smith IM; Shen Y; Walsh DM; Selkoe DJ Arch Neurol; 2009 Feb; 66(2):190-9. PubMed ID: 19204155 [TBL] [Abstract][Full Text] [Related]
18. Alpha 7 nicotinic acetylcholine receptor and its effects on Alzheimer's disease. Ma KG; Qian YH Neuropeptides; 2019 Feb; 73():96-106. PubMed ID: 30579679 [TBL] [Abstract][Full Text] [Related]
19. The nicotinic alpha7 acetylcholine receptor agonist ssr180711 is unable to activate limbic neurons in mice overexpressing human amyloid-beta1-42. Søderman A; Thomsen MS; Hansen HH; Nielsen EØ; Jensen MS; West MJ; Mikkelsen JD Brain Res; 2008 Aug; 1227():240-7. PubMed ID: 18619425 [TBL] [Abstract][Full Text] [Related]
20. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice. Hedberg MM; Clos MV; Ratia M; Gonzalez D; Lithner CU; Camps P; Muñoz-Torrero D; Badia A; Giménez-Llort L; Nordberg A Neurodegener Dis; 2010; 7(6):379-88. PubMed ID: 20689242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]